Get the Stockscreener App
130.00
1.59%
-2.10
Repligen Corp stock is traded at $130.00, with a volume of 753.21K.
It is down -1.59% in the last 24 hours and down -14.93% over the past month.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
See More
Previous Close:
$132.10
Open:
$131.26
24h Volume:
753.21K
Relative Volume:
1.04
Market Cap:
$7.15B
Revenue:
$633.51M
Net Income/Loss:
$-8.10M
P/E Ratio:
-419.35
EPS:
-0.31
Net Cash Flow:
$131.26M
1W Performance:
+12.86%
1M Performance:
-14.93%
6M Performance:
-8.54%
1Y Performance:
-19.24%
1-Day Range:
$125.24
$131.51
1-Week Range:
$111.20
$135.81
52-Week Range:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Name
Repligen Corp
Sector
Industry
Phone
(781) 449-9560
Address
41 SEYON STREET, WALTHAM, MA
Compare RGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
130.00 | 7.15B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
482.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
198.71 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.54 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
212.91 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.51 | 15.75B | 3.90B | 392.30M | 288.10M | 1.95 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-25 | Initiated | Evercore ISI | In-line |
| Feb-10-25 | Initiated | TD Cowen | Buy |
| Dec-17-24 | Initiated | Canaccord Genuity | Hold |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-18-24 | Initiated | Guggenheim | Neutral |
| Dec-04-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-20-23 | Initiated | Wells Fargo | Overweight |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Mar-28-23 | Initiated | The Benchmark Company | Buy |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-20-22 | Initiated | UBS | Buy |
| Oct-14-21 | Initiated | Exane BNP Paribas | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| May-07-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-23-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Nov-01-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Oct-15-19 | Initiated | SVB Leerink | Outperform |
| Aug-28-19 | Reiterated | First Analysis Sec | Outperform |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jul-22-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Dec-17-18 | Upgrade | CL King | Neutral → Buy |
| Nov-12-18 | Downgrade | CL King | Buy → Neutral |
| Sep-26-18 | Initiated | H.C. Wainwright | Neutral |
| Dec-08-17 | Initiated | Citigroup | Buy |
| Dec-05-17 | Initiated | JP Morgan | Overweight |
| Nov-13-17 | Initiated | CL King | Buy |
| Oct-02-17 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Jul-21-17 | Initiated | William Blair | Outperform |
| Feb-13-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
View All
Repligen Corp Stock (RGEN) Latest News
Repligen (NASDAQ:RGEN) Cut to “Sell” at StockNews.com - Defense World
Repligen to Report First Quarter 2025 Financial Results - The Globe and Mail
Repligen Corp (RGEN) Shares Up 4.7% on Apr 11 - GuruFocus
Hollow Fiber Filtration Market Future Business Opportunities - openPR.com
Repligen’s 39% decline validates InvestingPro’s bearish Fair Value call By Investing.com - Investing.com India
Repligen's 39% decline validates InvestingPro's bearish Fair Value call By Investing.com - Investing.com
Repligen (RGEN): Buy, Sell, Or Hold Post Q4 Earnings? - Barchart.com
Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
StockNews.com Upgrades Repligen (NASDAQ:RGEN) to "Hold" - MarketBeat
Analysts’ Revisions Show Improving Sentiment For Repligen Corp (NASDAQ: RGEN) - stocksregister.com
Repligen Appoints Jacob Johnson As Vice President Investor Relations - Yahoo Finance
Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last? - Yahoo Finance
Norges Bank Takes $24.03 Million Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen (NASDAQ:RGEN) Upgraded at StockNews.com - The AM Reporter
Repligen (NASDAQ:RGEN) Raised to Hold at StockNews.com - Defense World
Repligen stock touches 52-week low at $113.24 amid market shifts By Investing.com - Investing.com South Africa
Repligen stock touches 52-week low at $113.24 amid market shifts - Investing.com
Groupama Asset Managment Purchases 400,680 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Corient Private Wealth LLC Trims Stake in Repligen Co. (NASDAQ:RGEN) - Defense World
HighTower Advisors LLC Sells 180 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp (NASDAQ: RGEN): Getting A Free Pass? - Stocks Register
Repligen Co. (NASDAQ:RGEN) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Global Hollow Fiber Filtration Market to Witness Massive Growth - openPR.com
Envestnet Portfolio Solutions Inc. Lowers Holdings in Repligen Co. (NASDAQ:RGEN) - The AM Reporter
Is Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management? - Insider Monkey
Insider Buying: Margaret Pax Acquires Shares of Repligen Corp (R - GuruFocus
Repligen Corp (RGEN) Shares Gap Down to $139.34 on Mar 21 - GuruFocus.com
PNC Financial Services Group Inc. Sells 262 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp director Hunt Anthony sells $4.08 million in stock By Investing.com - Investing.com South Africa
Repligen Corp director Hunt Anthony sells $4.08 million in stock - Investing.com
Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth and valuation challenges - Investing.com
Repligen (NASDAQ:RGEN) Coverage Initiated by Analysts at Evercore ISI - Defense World
Proficio Capital Partners LLC Makes New Investment in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Co. (NASDAQ:RGEN) Shares Sold by Victory Capital Management Inc. - Defense World
Repligen director Pax Margaret acquires $37,672 in common stock By Investing.com - Investing.com Australia
Repligen director Pax Margaret acquires $37,672 in common stock - Investing.com
REPLIGEN Director Margaret Pax Acquires 250 Shares - TradingView
Evercore ISI sets Repligen stock In Line with $155 price target - Investing.com
Demystifying Repligen: Insights From 6 Analyst Reviews - Benzinga
Repligen initiated with an In Line at Evercore ISI - TipRanks
Repligen Corp (RGEN) Shares Up 5.72% on Mar 17 - GuruFocus.com
Repligen Corp (RGEN) Shares Up 5.72% on Mar 15 - GuruFocus.com
REPLIGEN CORP SEC 10-K Report - TradingView
Charles Schwab Investment Management Inc. Grows Position in Repligen Co. (NASDAQ:RGEN) - Defense World
William Blair Brokers Reduce Earnings Estimates for Repligen - Defense World
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack - The Globe and Mail
Oppenheimer & Co. Inc. Purchases New Shares in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corporation’s Acquisition of Bioprocessing PAT Device Portfolio from 908 Devices - Global Legal Chronicle
US Bancorp DE Raises Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen buying 908 Devices’ Bioprocess Analytics portfolio - BioWorld Online
Sanctuary Advisors LLC Sells 268 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp Stock (RGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
3.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):